TEVA PHARMACEUTICAL FIN LLC - DBCV 0.250% 2/0

CUSIP: 88163VAE9

Q4 2013 13F Holders as of 31 Dec 2013

Type / Class
Debt / DBCV 0.250% 2/0
Market price (% of par)
106.2%
Total 13F principal
$406,080,142
Principal change
-$13,191,111
Total reported market value
$432,801,995
Number of holders
43
Value change
-$13,966,026
Number of buys
2
Number of sells
3

Quarterly Holders Quick Answers

What is CUSIP 88163VAE9?
CUSIP 88163VAE9 identifies 88163VAE9 - TEVA PHARMACEUTICAL FIN LLC - DBCV 0.250% 2/0 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of TEVA PHARMACEUTICAL FIN LLC - DBCV 0.250% 2/0 as of Q4 2013

As of 31 Dec 2013, TEVA PHARMACEUTICAL FIN LLC - DBCV 0.250% 2/0 was held by 43 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $406,080,142 in principal (par value) of the bond. The largest 10 bondholders included ZAZOVE ASSOCIATES LLC, MACKAY SHIELDS LLC, Lombard Odier Asset Management (Europe) Ltd, Invesco Ltd., VICTORY CAPITAL MANAGEMENT INC, Ferox Capital Management LP, Thrivent Financial for Lutherans, F&C Asset Management plc, DEUTSCHE BANK AG\, and CALAMOS ADVISORS LLC. This page lists 43 institutional bondholders reporting positions for the Q4 2013 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.